FRANKFURT (Reuters) – Bayer said on Friday it was considering challenging a verdict awarding it $275 million in damages after a jury ruled in favor of a group of plaintiffs in connection with the coronavirus infections. PCB, a chemical produced by Monsanto until 1977.
The verdict was returned by the King County Superior Court in the US state of Washington in favor of 13 plaintiffs who attribute their illnesses to exposure to polychlorinated biphenyls, or PCBs, at Sky Valley School in the county of Monroe, Bloomberg and other media reported Thursday.
“We respectfully disagree with the jury’s split verdict in this case involving 13 plaintiffs and we plan to make post-trial motions and appeals due to the multiple errors and lack of evidence at trial,” Bayer said. in a press release.
The Bayer title was down 0.7% at 09:15 GMT, while the German DAX index was up 0.5%.
Already sued over Monsanto’s Roundup pesticide, Bayer must also deal with consequences related to PCB, a chemical used until Monsanto stopped production in 1977.
Since 2020, Bayer has resolved the majority of disputes with municipalities over PCB-contaminated wastewater worth $650 million, but several other claims are pending.
In August, it provisioned 694 million euros as part of an agreement with the State of Oregon concerning the presence of PCBs in wastewater.
This group of substances was once used in electrical equipment, flooring and paint and was banned by the US government in 1979 after being linked to the development of cancer.
(Report Ludwig Burger; French version Kate Entringer, edited by Sophie Louet)